Glaukos - 51 Year Dividend History | GKOS

Historical dividend payout and yield for Glaukos (GKOS) since 1971. The current TTM dividend payout for Glaukos (GKOS) as of November 25, 2022 is $0.00. The current dividend yield for Glaukos as of November 25, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.263B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio